DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tesaro
Tesaro
List of Medicinal Products Under Additional Monitoring
Eortc-1307-Bcg) (Big5-13) (Tesaro Pr-30-5010-C)
January 2020: Additions and Deletions to the Drug Product List
Final Belgian List
Antibodies to Watch in 2021 Hélène Kaplona and Janice M
Available Medications and Supplies
GSK Delivers Q2 Sales of £7.6 Billion -2% AER, -3% CER (Pro-Forma -10% CER*) Total EPS 45.5P >100% AER; >100% CER; Adjusted EPS 19.2P -37% AER, -38% CER
October Through December 2013
Wednesday, February 14, 2018 4:00Pm
Annual Report 2020 We Are a Science-Led Global Healthcare Company
Drug Pipeline Monthly Update September 2017
5 CLINICAL NEWS 16 FINANCIAL NEWS Deals, Sales & Marketing, Other Regulatory, Clinical Results, Completed Offerings, Other News Clinical Status Financial News
Group Companies
GSK Investor Presentation
Press Release Full Year and Fourth Quarter 2020
Remuneration
Clinical Pharmacology Biopharmaceutics Review(S)
April 2017 a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS
Top View
Minutes of PRAC Meeting on 09 -12 March 2020
ACCC Patient Assistance and Reimbursement Guide
CHMP December 2018 Agenda for Publication
Takeda Pinpoints Four Infectious Diseases Under Vaccines Strategy
January Through March 2014
Investor Information Information Investor Information
Acitretin Prior Authorization Guidelines
Investor Information Information Investor Information
PRAC Draft Agenda of Meeting 8-11 April 2019
Press Release Full Year and Fourth Quarter 2018
January 2021 Hikes for Posting
October 2017 a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS
Annual Report 2018 GSK Annual Report 2018
March 2017: Additions and Deletions to the Drug Product List
Study Protocol 3000-PN162-01-001 Amendment 2
CDER Drug and Biologic Approvals for Calendar Year 2017
Prescription and Over-The-Counter Drug Product List 38TH EDITION Cumulative Supplement Number 06 : June 2018 ADDITIONS/DELETIONS for PRESCRIPTION DRUG PRODUCT LIST
Orange Book Cumulative Supplement 09 September 2015
FY 2017 PDUFA Performance Report Commissioner’S Report
Cancer PRESENTEDBYAMERICA ’ SBIOPHARMACEUTICALRESEARCHCOMPANIES Nearly 900 Medicines and Vaccines in Testing Offer Hope in the Fight Against Cancer
Wednesday, December 13, 2017 4 P.M
Teva Lands a CEO: Can Schultz Replicate
Endometriomasendometriomas Classificlassifi Catcationion a Nandd Surgicalsurgical Mamanagementnagement